在静脉血栓栓塞的抗凝固药物一般医生
Katherine Stark1, Abhinav Mathur1, Mohammed M Khan1
1Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, NHS Grampian, Aberdeen, UK.
The journal of the Royal College of Physicians of Edinburgh
|March 29, 2024
概括
本综述详细介绍了静脉血栓栓塞 (VTE) 的当前抗凝疗实践,根据证据和指导方针指导治疗选择和持续时间. 它涵盖了癌症和抗脂综合征等特殊病例.
科学领域:
- 医学 医学 医学 医学 医学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 静脉血栓栓塞 (VTE) 是一种常见且严重的疾病,需要谨慎管理.
- 抗凝血是静脉瘤治疗的基石,但最佳策略是复杂的.
- 目前的指导方针强调了对VTE的个性化治疗计划.
研究的目的:
- 提供基于证据的对VTE目前的抗凝血实践的综述.
- 总结关于VTE管理的国家和国际指南.
- 讨论影响VTE抗凝药选择和持续时间的因素.
主要方法:
- 这是一篇基于证据的综述文章.
- 它综合了当前的文献和临床指南.
- 分析了关键决策因素和特殊情况.
主要成果:
- 在VTE管理中,抗凝药的选择和持续时间是多因素的.
- 特殊人群,包括患有癌症或抗脂综合征的人群,需要量身定制的方法.
- 在VTE管理中对血栓友爱查的作用进行了批判性评估.
结论:
- 对静脉血栓炎的最佳抗凝药需要考虑个体患者因素的细微方法.
- 遵守基于证据的指导方针可以确保有效的VTE管理.
- 进一步的研究可能会在特定的VTE病例中完善血栓性查的实用性.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
690
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
690
Esophageal Varices-II: Clinical Features and Management
60
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
60
Venous Return
4.1K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
4.1K
Disorders of Hemostasis
885
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
885
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522


